Aksan has advised Pharmacontract on obtaining clearance from the Turkish Competition Board for the acquisition of unspecified subsidiaries in Italy.
Pharmacontract is a joint venture of Trilantic Europe and Alto Partners.
Trilantic Europe and Alto Partners are private equity groups.
According to Aksan, the subsidiaries in question are engaged in the development and manufacturing of pharmaceuticals.
The Aksan team included Senior Partner Onur Ergun.
